The Division of Rheumatology, Inflammation, and Immunity at Brigham and Women's Hospital has one of the largest research funding bases and investigative teams of any rheumatology program in the country. The discoveries of our researchers in the areas of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and many other rheumatic diseases have transformed the practice of rheumatology and continue to improve the prognosis for patients.
Researchers in our division are investigating the underlying causes of rheumatic, inflammatory and immunologic disorders and are developing groundbreaking approaches to prevention and treatment. We study the full range of rheumatic diseases, including osteoarthritis, RA, lupus, gout, psoriatic arthritis, vasculitis and many others.
Since the division's inception in 1974, our research has been continuously funded by the National Institutes of Health. Our annual research funding is over $27 million, including $20 million from the NIH, and our research team includes 23 faculty and 20 trainees.
Our laboratories and clinics are co-located at the Hale Building for Transformative Medicine. The facility brings together research, clinical care and education to accelerate the translation of research into more sophisticated, precise and personalized care. The Hale Building features eight floors of research space, including basic, translational and clinical research, patient information and consent rooms for clinical trials and an advanced imaging suite.
Learn about our large and acclaimed team of basic, translational and clinical researchers along with their labs.